Alhassane Diallo (A Diallo)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Systematic Review

Psychometric Properties

Cardiovascular Events

Top Venues

Diabetes, obesity & metabolism

Zeitschrift fur Gesundheitswissenschaften = Journal of public health

Human vaccines & immunotherapeutics

Acta diabetologica

This page only lists publications with an associated author ORCID identifier.

Publications

Alhassane Diallo, M F Diallo, M Carlos-Bolumbu, Florence Galtier
Uric acid-lowering effects of sodium-glucose cotransporter 2 inhibitors for preventing cardiovascular events and mortality: A systematic review and meta-analysis. Diabetes, obesity & metabolism 26 (5) (2024)
Alhassane Diallo, M F Diallo, M Carlos-Bolumbu, Florence Galtier
Uric acid-lowering effects of sodium-glucose cotransporter 2 inhibitors for preventing cardiovascular events and mortality: A systematic review and meta-analysis. Diabetes, obesity & metabolism (2024)
Alhassane Diallo, M F Diallo, M Carlos-Bolumbu, Florence Galtier
Uric acid-lowering effects of sodium-glucose cotransporter 2 inhibitors for preventing cardiovascular events and mortality: A systematic review and meta-analysis. Diabetes, obesity & metabolism 26 (5) (2024)
Alhassane Diallo, Miguel Carlos-Bolumbu, Florence Galtier
Blood pressure-lowering effects of SGLT2 inhibitors and GLP-1 receptor agonists for preventing of cardiovascular events and death in type 2 diabetes: a systematic review and meta-analysis. Acta diabetologica (2023)
Alhassane Diallo, Orianne Villard, Miguel Carlos-Bolumbu, Pr Eric Renard, Florence Galtier
Effects of hypoglycaemic agents on reducing surrogate metabolic parameters for the prevention of cardiovascular events and death in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism (2023)
Alhassane Diallo, Miguel Carlos-Bolumbu, Florence Galtier
Is composite cardiovascular death or hospitalization for heart failure a valid surrogate for mortality in patients treated with sodium-glucose cotransporter 2 inhibitors? A correlation meta-analysis. Diabetes, obesity & metabolism (2023)
Alhassane Diallo, Miguel Carlos-Bolumbu, Pr Eric Renard, Florence Galtier
Larger effect size in composite kidney outcomes than in major cardiovascular events associated with sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with glucagon-like peptide-1 receptor agonists (GLP-1RAs): A pooled analysis of type 2 diabetes trials. Diabetes, obesity & metabolism (2022)
Alhassane Diallo, Miguel Carlos-Bolumbu, Mamadou Hassimiou Diallo, Alain Makinson, Florence Galtier
Efficacy of approved vaccines to prevent COVID-19: a systematic review and network meta-analysis of reconstructed individual patient data from randomized trials. Zeitschrift fur Gesundheitswissenschaften = Journal of public health (2022)
Alhassane Diallo, Miguel Carlos-Bolumbu, Minerva Cervantes-Gonzalez, Veronika Wozniak, Mamadou Hassimiou Diallo, Boubacar Djelo Diallo, Alexandre Delamou, Florence Galtier
Immunogenicity and safety of Ebola virus vaccines in healthy adults: a systematic review and network meta-analysis. Human vaccines & immunotherapeutics 17 (10) (2021)
Alhassane Diallo, Matthieu Pichelin, Matthieu Wargny, Pierre Gourdy, Jean-Baptiste Bonnet, Samy Hadjadj, Bertrand Cariou, Ariane Sultan, Florence Galtier, null null
Influenza vaccination and prognosis for COVID-19 in hospitalized patients with diabetes: Results from the CORONADO study. Diabetes, obesity & metabolism (2021)